| Dr Patrick James Haas, MD | |
|
40 N Grand Ave, Suite 103, Fort Thomas, KY 41075-4107 | |
| (859) 572-3031 | |
| (859) 572-3045 |
| Full Name | Dr Patrick James Haas |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 14 Years |
| Location | 40 N Grand Ave, Fort Thomas, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104137454 | NPI | - | NPPES |
| T2320 | Other | MS | MEDICAL LICENSE |
| 47927 | Other | KY | MEDICAL LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| Dearborn County Hospital | Lawrenceburg, IN | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Head And Neck Surgery Associates, Psc | 4183662158 | 22 |
| Head And Neck Surgery Associates, Psc | 4183662158 | 22 |
| Head And Neck Surgery Associates, Psc | 4183662158 | 22 |
News Archive
Adults with pre-diabetes can lose up to 3 percent of their body weight using diet, exercise and behavioral strategies, according to a systematic review of studies that analyzed weight-loss strategies for pre-diabetics.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Although people can seek exemptions from this requirement to buy coverage, only about 77,000 have done so, The Washington Post reports. Meanwhile, payment issues are also in the headlines as KHN looks at insurers' efforts to set the 2015 rates for policies on the health law's marketplaces, and the New York Times examines a panel's findings about the law's effects on doctors and hospitals treating many poor patients.
Defects in a key gene - long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes - spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
› Verified 9 days ago
| Entity Name | Head And Neck Surgery Associates, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760569545 PECOS PAC ID: 4183662158 Enrollment ID: O20050420000600 |
News Archive
Adults with pre-diabetes can lose up to 3 percent of their body weight using diet, exercise and behavioral strategies, according to a systematic review of studies that analyzed weight-loss strategies for pre-diabetics.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Although people can seek exemptions from this requirement to buy coverage, only about 77,000 have done so, The Washington Post reports. Meanwhile, payment issues are also in the headlines as KHN looks at insurers' efforts to set the 2015 rates for policies on the health law's marketplaces, and the New York Times examines a panel's findings about the law's effects on doctors and hospitals treating many poor patients.
Defects in a key gene - long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes - spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick James Haas, MD 40 N Grand Ave, Suite 103, Fort Thomas, KY 41075-4107 Ph: (859) 572-3031 | Dr Patrick James Haas, MD 40 N Grand Ave, Suite 103, Fort Thomas, KY 41075-4107 Ph: (859) 572-3031 |
News Archive
Adults with pre-diabetes can lose up to 3 percent of their body weight using diet, exercise and behavioral strategies, according to a systematic review of studies that analyzed weight-loss strategies for pre-diabetics.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Although people can seek exemptions from this requirement to buy coverage, only about 77,000 have done so, The Washington Post reports. Meanwhile, payment issues are also in the headlines as KHN looks at insurers' efforts to set the 2015 rates for policies on the health law's marketplaces, and the New York Times examines a panel's findings about the law's effects on doctors and hospitals treating many poor patients.
Defects in a key gene - long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes - spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
› Verified 9 days ago
Dr. Thomas Milton Mayer, M.D., FACS Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 40 N Grand Ave, Suite 101, Fort Thomas, KY 41075 Phone: 859-781-4900 Fax: 859-572-3044 | |
Dr. Perry Stephen Poteet, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Ste.101, Fort Thomas, KY 41075 Phone: 937-475-3327 | |
Dr. Michael Anthony Domet, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Suite 101, Fort Thomas, KY 41075 Phone: 859-781-4900 Fax: 859-572-3044 | |
Thomas Kyle Hamilton, M.D., M.SC. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Ste 101, Fort Thomas, KY 41075 Phone: 513-475-8400 Fax: 513-475-8228 | |
Dr. Todd M. Kirchhoff, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Suite 101, Fort Thomas, KY 41075 Phone: 859-781-4900 Fax: 859-572-3044 | |
Dr. James Jay Kempiners, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Suite 101, Fort Thomas, KY 41075 Phone: 859-781-4900 Fax: 859-572-3044 |